Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Head Cancer Neck: early-phase trial registry

1 of 2 indexed Head Cancer Neck trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · 1 currently recruiting · #7,188 of 28,707 conditions by registered trial count

Head Cancer Neck: 2 US clinical trials tracked, 1 recruiting.

Head Cancer Neck is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is NYU Langone Health, running 1 of these trials.

Enrollment posture brief

Registry condition head-cancer-neck

OPEN 1 | RECR 50% | LATE 0 | EARLY 1 | RANK #7188 | SPON 1

Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Head Cancer Neck (this)50%
Open-enrollment share among volume-matched conditions near Head Cancer Neck

Head Cancer Neck lists 1 open slots (50% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Head Cancer Neck on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Head Cancer Neck is recruiting above its size-band peers.

    1 of 2 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 11

Phase Distribution

PhaseTrial count
Phase 1 1

Named interventions

Most-linked intervention names on Head Cancer Neck records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

MRI with gadolinium Radiation
1 trials
MRI scan without contrast Radiation
1 trials
PET/MRI with FDG Radiation
1 trials
Cetuximab Drug
1 trials
Cisplatin Drug
1 trials
Cemiplimab Drug
1 trials
Docetaxel Drug
1 trials
Carboplatin Drug
1 trials

US sites by state

Facility locations filed on Head Cancer Neck trials. A trial with sites in several states counts in each.

New York 2 trials
New Jersey 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Head Cancer Neck page

2 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Head Cancer Neck condition card totals 2 registered trials; most-linked intervention MRI with gadolinium; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.